Literature DB >> 11339860

Intra-monocyte pathogens delineate autism subgroups.

T Binstock1.   

Abstract

Immune panels of many autism-spectrum children reveal signs of atypical infections and shifted cell counts. In conjunction with trait-related cerebral hypometabolism and hypoperfusion, these findings suggest a hypothesis: Several autism-spectrum subgroups derive from intra-monocyte pathogens such as measles virus, cytomegalovirus, human herpesvirus 6, and Yersinia enterocolitica. Furthermore, with much inter-child variation, their effects manifest as diminished hematopoiesis, impaired peripheral immunity, and altered blood-brain barrier function often accompanied by demyelination. In some such children, one or more of these pathogens persists as a chronic-active, seemingly subclinical infection etiologically significant to the child's autistic traits. Within these subgroups, immune impairments and atypical infections may be treatable. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11339860     DOI: 10.1054/mehy.2000.1247

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

Review 1.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Brief Report: Low Rates of Herpesvirus Detection in Blood of Individuals with Autism Spectrum Disorder and Controls.

Authors:  Thayne L Sweeten; Lisa A Croen; Gayle C Windham; J Dennis Odell; E Gene Stubbs; Anthony R Torres
Journal:  J Autism Dev Disord       Date:  2019-01

Review 3.  Brief report: immune factors in autism: a critical review.

Authors:  Ilan Krause; Xiao-Song He; M Eric Gershwin; Yehuda Shoenfeld
Journal:  J Autism Dev Disord       Date:  2002-08

Review 4.  Is fever suppression involved in the etiology of autism and neurodevelopmental disorders?

Authors:  Anthony R Torres
Journal:  BMC Pediatr       Date:  2003-09-02       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.